Tumor-specific deletions encompassing ARID1B have been reported in central nervous system tumors [27], and multiple members of this complex have been identified as tumor suppressor genes in ovarian cancer, pancreatic cancer, liver cancer, and neuroblastoma [6, 19, 28–30]. This evidence concerns the gene ARID1B and ovarian carcinoma.